Linaprazan
Linaprazan (AZD0865) is a potassium-competitive acid blocker (P-CAB) that reversibly inhibits gastric H+, K+-ATPase with an IC50 of 1.0 μM. This small molecule is a research tool for investigating acid-suppressive therapies in both in vitro biochemical assays and in vivo models of gastric acid-related disorders.
Product Specifications
CAS Number
248919-64-4
Product Name Alternative
Inhibitor, Linaprazan, inhibit, K+-competitive binding, AZD0865, AZD-0865, AZD 0865, Proton Pump, Potassium Channel, PotassiumChannel
Field of Research
Pharmacology & Drug Discovery
Purity
99.54% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.73 mM) ; DMSO:3.67 mg/mL (10.01 mM)
Smiles
Cc1nc2c (NCc3c (C) cccc3C) cc (cn2c1C) C (=O) NCCO
Molecular Formula
C21H26N4O2
Molecular Weight
366.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog